3.85 -0.01 (-0.26%)

54.38% Fall from 52W High

23,229 XNAS Volume

XNAS 24 Mar, 2025 9:51 AM (EDT)



Insider Trading disclosures for biote Corp - Ordinary Shares - Class A

The latest disclosure was made by Marc D. Beer in biote Corp - Ordinary Shares - Class A where a trade of 107,794 Class A Common Stock done at an average price of $3.9 was reported to US exchanges on March 17, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Marc D. Beer Director Purchase of securities on an exchange or from another person at price $ 3.87 per share. 17 Mar 2025 107,794 107,794 - 3.9 417,163 Class A Common Stock
Bret Christensen Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 3.87 per share. 17 Mar 2025 37,595 37,595 - 3.9 145,493 Class A Common Stock
Stephen Mark Cone Director Purchase of securities on an exchange or from another person at price $ 3.88 per share. 17 Mar 2025 38,104 160,829 - 3.9 147,844 Class A Common Stock
Andrew R. Heyer Director Purchase of securities on an exchange or from another person at price $ 3.95 per share. 17 Mar 2025 50,000 1,523,513 - 3.9 197,380 Class A Common Stock
Andrew R. Heyer Director Purchase of securities on an exchange or from another person at price $ 3.95 per share. 17 Mar 2025 25,000 370,201 - 3.9 98,663 Class A Common Stock
Bret Christensen Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2025 1,500,000 1,500,000 - - Employee Stock Option (Right to Buy)
Robert C. Peterson Chief Financial Officer Sale of securities on an exchange or to another person at price $ 6.20 per share. 09 Sep 2024 32,874 0 - 6.2 203,848 Class A Common Stock
Robert C. Peterson Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jul 2024 44,250 44,250 - 0 Class A Common Stock
Robert C. Peterson Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jul 2024 44,250 0 - - Restricted Stock Unit
Robert C. Peterson Chief Financial Officer Sale of securities on an exchange or to another person at price $ 7.57 per share. 08 Jul 2024 11,376 32,874 - 7.6 86,084 Class A Common Stock
Andrew R. Heyer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 65,258 175,459 - - Stock Option (Right to Buy)
Andrew R. Heyer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 13,427 25,436 - - Deferred Settlement RSU
Steven J. Heyer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 65,258 175,459 - - Stock Option (Right to Buy)
Debra L. Morris Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 65,258 153,657 - - Stock Option (Right to Buy)
Debra L. Morris Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2024 9,110 39,110 - - Class A Common Stock
Debra L. Morris Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2024 9,110 0 - - Deferred Settlement RSU
Debra L. Morris Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 10,395 10,395 - - Deferred Settlement RSU
Dana Jacoby Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2024 11,595 0 - - Deferred Settlement RSU
Dana Jacoby Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 65,258 143,763 - - Stock Option (Right to Buy)
Dana Jacoby Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 12,994 12,994 - - Deferred Settlement RSU
Dana Jacoby Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2024 11,595 50,970 - - Class A Common Stock
Stephen Mark Cone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 10,828 20,352 - - Deferred Settlement RSU
Stephen Mark Cone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 65,258 143,763 - - Stock Option (Right to Buy)
Debra L. Morris Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 11,045 11,045 - - Deferred Settlement RSU
Marc D. Beer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2024 543,958 1,338,842 - - Employee Stock Option (Right to Buy)
Teresa S. Weber Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2024 777,083 2,669,663 - - Employee Stock Option (Right to Buy)
Mary Elizabeth Conlon General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2024 164,413 422,574 - - Employee Stock Option (Right to Buy)
Robert Peterson Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 400,000 400,000 - - Employee Stock Option (Right to Buy)
Robert Peterson Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 44,250 44,250 - - Restricted Stock Unit
Mary Elizabeth Conlon General Counsel Sale of securities on an exchange or to another person at price $ 6.50 per share. 05 Jul 2023 6,240 140,393 - 6.5 40,573 Class A Common Stock
Dana Jacoby Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2023 6,058 0 - - Phantom Stock
Dana Jacoby Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2023 6,058 39,375 - - Class A Common Stock
Mary Elizabeth Conlon General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2023 24,231 146,633 - - Class A Common Stock
Mary Elizabeth Conlon General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2023 24,231 0 - - Phantom Stock
Stephen Mark Cone Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2023 6,058 0 - - Phantom Stock
Stephen Mark Cone Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2023 6,058 122,725 - - Class A Common Stock
Mary Joan Puncochar Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 221,500 221,500 - - Employee Stock Option (Right to Buy)
Marc D. Beer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2023 317,163 794,884 - - Stock Option (Right to Buy)
Andrew R. Heyer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2023 46,809 110,201 - - Stock Option (Right to Buy)
Andrew R. Heyer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2023 12,009 12,009 - - Deferred Settlement RSU
Steven J. Heyer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2023 46,809 110,201 - - Stock Option (Right to Buy)
Debra L. Morris Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2023 25,007 88,399 - - Stock Option (Right to Buy)
Debra L. Morris Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2023 9,110 9,110 - - Deferred Settlement RSU
Dana Jacoby Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2023 46,809 78,505 - - Stock Option (Right to Buy)
Dana Jacoby Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2023 11,595 11,595 - - Deferred Settlement RSU
Stephen Mark Cone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2023 9,524 9,524 - - Deferred Settlement RSU
Stephen Mark Cone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2023 46,809 78,505 - - Stock Option (Right to Buy)
Mary Elizabeth Conlon General Counsel Sale of securities on an exchange or to another person at price $ 5.92 per share. 04 Apr 2023 10,867 122,402 - 5.9 64,383 Class A Common Stock
Teresa S. Weber Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2023 755,150 1,892,580 - - Employee Stock Option (Right to Buy)
Mary Elizabeth Conlon General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2023 135,000 258,161 - - Employee Stock Option (Right to Buy)
Samar Jagat Kamdar Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2023 45,000 295,000 - - Employee Stock Option (Right to Buy)
Dana Jacoby Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 9,844 6,058 - - Phantom Stock
Dana Jacoby Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 9,844 33,317 - - Class A Common Stock
Mary Elizabeth Conlon General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 39,375 24,231 - - Phantom Stock
Mary Elizabeth Conlon General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 39,375 133,269 - - Class A Common Stock
Stephen Mark Cone Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 9,844 116,667 - - Class A Common Stock
Stephen Mark Cone Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 9,844 6,058 - - Phantom Stock
Andrew R. Heyer Director Purchase of securities on an exchange or from another person at price $ 3.00 per share. 09 Jan 2023 100,000 1,473,513 - 3 300,000 Class A Common Stock
Andrew R. Heyer Director Purchase of securities on an exchange or from another person at price $ 3.00 per share. 09 Jan 2023 100,000 345,201 - 3 300,000 Class A Common Stock
Debra L. Morris Director Purchase of securities on an exchange or from another person at price $ 3.00 per share. 09 Jan 2023 30,000 30,000 - 3 90,000 Class A Common Stock
Stephen Mark Cone Director Purchase of securities on an exchange or from another person at price $ 3.00 per share. 09 Jan 2023 83,350 106,823 - 3 250,050 Class A Common Stock
Samar Jagat Kamdar Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 3.00 per share. 09 Jan 2023 13,000 13,000 - 3 39,000 Class A Common Stock
Marc D. Beer Director Other type of transaction at price $ 0.00 per share. 06 Jan 2023 865,384 2,967,092 - 0 Class V Common Stock
Marc D. Beer Director 06 Jan 2023 865,384 2,967,092 - - Retained Biote Units
Marc D. Beer Director Sale of securities on an exchange or to another person at price $ 3.00 per share. 06 Jan 2023 865,384 0 - 3 2,596,152 Class A Common Stock
Marc D. Beer Director 06 Jan 2023 865,384 865,384 - 0 Class A Common Stock
Teresa S. Weber Director, Chief Executive Officer Other type of transaction at price $ 0.00 per share. 06 Jan 2023 865,384 2,967,092 - 0 Class V Common Stock
Teresa S. Weber Director, Chief Executive Officer 06 Jan 2023 865,384 2,967,092 - - Retained Biote Units
Teresa S. Weber Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 3.00 per share. 06 Jan 2023 865,384 85,040 - 3 2,596,152 Class A Common Stock
Teresa S. Weber Director, Chief Executive Officer 06 Jan 2023 865,384 950,424 - 0 Class A Common Stock
Dana Jacoby Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Dec 2022 9,844 15,902 - - Phantom Stock
Dana Jacoby Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Dec 2022 9,844 23,473 - - Class A Common Stock
Mary Elizabeth Conlon General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Dec 2022 39,375 63,606 - - Phantom Stock
Mary Elizabeth Conlon General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Dec 2022 39,375 93,894 - - Class A Common Stock
Stephen Mark Cone Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Dec 2022 9,844 15,902 - - Phantom Stock
Stephen Mark Cone Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Dec 2022 9,844 23,473 - - Class A Common Stock
Marc D. Beer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2022 477,721 477,721 - - Stock Option (Right to Buy)
Andrew R. Heyer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2022 63,392 63,392 - - Stock Option (Right to Buy)
Steven J. Heyer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2022 63,392 63,392 - - Stock Option (Right to Buy)
Debra L. Morris Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2022 63,392 63,392 - - Stock Option (Right to Buy)
Dana Jacoby Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2022 31,696 31,696 - - Stock Option (Right to Buy)
Stephen Mark Cone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2022 31,696 31,696 - - Stock Option (Right to Buy)
Dana Jacoby Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2022 13,629 25,746 - - Phantom Stock
Dana Jacoby Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2022 13,629 13,629 - - Class A Common Stock
Robbin Gibbins Chief Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2022 102,115 192,885 - - Phantom Stock
Robbin Gibbins Chief Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2022 102,115 102,115 - - Class A Common Stock
Mary Elizabeth Conlon General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2022 54,519 54,519 - - Class A Common Stock
Mary Elizabeth Conlon General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2022 54,519 102,981 - - Phantom Stock
Stephen Mark Cone Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2022 13,629 25,746 - - Phantom Stock
Stephen Mark Cone Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2022 13,629 13,629 - - Class A Common Stock
Teresa S. Weber Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2022 1,137,430 1,137,430 - - Employee Stock Option (Right to Buy)
Teresa S. Weber Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Sep 2022 85,040 85,040 - 0 Class A Common Stock
Robbin Gibbins Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2022 105,049 105,049 - - Employee Stock Option (Right to Buy)
Mary Elizabeth Conlon General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2022 123,161 123,161 - - Employee Stock Option (Right to Buy)
Samar Jagat Kamdar Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2022 250,000 250,000 - - Employee Stock Option (Right to Buy)
Andrew R. Heyer Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 19 Jul 2022 4,072,862 536,236 - - Private Placement Warrants
Andrew R. Heyer Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 19 Jul 2022 5,120,344 643,643 - 0 Class A Common Stock
Steven J. Heyer Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 19 Jul 2022 4,123,929 0 - - Private Placement Warrants
Steven J. Heyer Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 19 Jul 2022 6,407,644 0 - 0 Class A Common Stock
Marc D. Beer Director Other type of transaction at price $ 0.00 per share. 26 May 2022 654,387 3,832,476 - - Retained Biote Units
Marc D. Beer Director Other type of transaction at price $ 0.00 per share. 26 May 2022 654,387 3,832,476 - 0 Class V Common Stock
Andrew R. Heyer Director, Ten Percent Owner 26 May 2022 7,937,500 0 - - Class B Common Stock
Andrew R. Heyer Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2022 5,566,666 5,566,666 - - Private Placement Warrants
Andrew R. Heyer Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 May 2022 7,937,500 7,937,500 - 0 Class A Common Stock
Andrew R. Heyer Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 26 May 2022 800,000 7,137,500 - 0 Class A Common Stock
Steven J. Heyer Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 26 May 2022 800,000 7,137,500 - 0 Class A Common Stock
Steven J. Heyer Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 May 2022 7,937,500 7,937,500 - 0 Class A Common Stock
Steven J. Heyer Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2022 5,566,666 5,566,666 - - Private Placement Warrants
Steven J. Heyer Director, Ten Percent Owner 26 May 2022 7,937,500 0 - - Class B Common Stock
Dana Jacoby Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2022 39,375 39,375 - - Phantom Stock
Teresa S. Weber Director, Chief Executive Officer Other type of transaction at price $ 0.00 per share. 26 May 2022 654,387 3,832,476 - - Retained Biote Units
Teresa S. Weber Director, Chief Executive Officer Other type of transaction at price $ 0.00 per share. 26 May 2022 654,387 3,832,476 - 0 Class V Common Stock
Robbin Gibbins Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2022 295,000 295,000 - - Phantom Stock
Mary Elizabeth Conlon General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2022 157,500 157,500 - - Phantom Stock
Stephen Mark Cone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2022 39,375 39,375 - - Phantom Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures